Biopharma Co. Sues Over Cancer Drug Clinical Trial Mix-Up

Law360, New York (September 26, 2012, 2:40 PM ET) -- Peregrine Pharmaceuticals Inc. on Monday sued a clinical testing company in California federal court, alleging it mixed up the results of a clinical trial for a new cancer treatment, causing Peregrine to have to rescind its promising trial results.

According to the Tustin, Calif.-based biopharmaceutical company’s complaint, Fargo, N.D.-based Clinical Supplies Management Inc. ran one of three randomized, double-blind, placebo-controlled Phase II trials for the drug bavituximab as part of a testing services agreement with Peregrine. Bavituximab, a first-of-its-kind monoclonal antibody treatment that prompts the immune system...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Peregrine Pharmaceuticals Inc v. Clinical Supplies Management Inc


Case Number

8:12-cv-01608

Court

California Central

Nature of Suit

Contract: Other

Judge

Jesus G. Bernal

Date Filed

September 24, 2012

Law Firms

Companies